Navigation Links
Alexza Provides Pipeline Update
Date:7/31/2014

er currently available options for treating these symptoms.  Alexza believes that rapidly treating the acute symptoms could address a need in RLS patients for whom the acute symptoms can seriously impair quality of life.

AZ-009 (Staccato ropinirole) for Hypomobility in PD
According to the Parkinson's Disease Foundation, as many as one million people in the United States live with PD, which is a progressive neurodegenerative disorder that is characterized by a broad spectrum of motor and non-motor features that can have an impact on the function of the patient.   One of these clinical features is acute and intermittent hypomobility, or freezing, during "off periods", which tends to manifest in the more advanced patients. 

Freezing is a form of akinesia (loss of movement) and is one of the most disabling symptoms of PD.  It may occur in about half of PD patients and according to Alexza's physician survey (n=111), can occur at any time of the day, and multiple times per day or week depending on the patient.  Freezing most commonly affects the legs during walking, and because of this, is a common cause of falls, which can cause substantial social and clinical consequences for patients.  Alexza's interviews with neurologists who specialize in treating PD describe a freezing episode as unpredictable and sudden, and lasting 10 to 30 minutes.  Although these freezing episodes can be mitigated by treatment with dopamine agonists, only oral and injectable treatment options are currently available for patients to treat themselves at home.

According to neurologists Alexza surveyed (n=111) who specialize in treating these patients, AZ-009 could play a role in treating the PD population that is currently underserved with current treatment options for freezing.  According to the physicians Alexza surveyed, speed of onset of treatment is considered crucial in treating the
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
2. Alexza Receives Complete Response Letter for Adasuveā„¢ NDA
3. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
4. Alexza Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
5. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
6. Alexza Announces Management Promotions
7. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
8. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
9. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
10. Alexza to Report 2012 Year-End Financial Results on Tuesday, March 26, 2013
11. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 CVS Health Corporation (NYSE: CVS ... May 1, 2015, at 8:30 a.m. (EDT) with analysts ... An audio webcast of the conference call ... of the CVS Health website for all interested parties. ... webcast will be archived and available on the web ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ... Testing - Global Strategic Business Report" report to ... markets for ADME-Toxicology Testing in US$ Million by the ... Testing. The report provides separate comprehensive analytics ... Japan , Europe , ...
(Date:4/17/2015)... DIEGO , April 17, 2015  Trovagene, ... diagnostics, announced today that clinical data presented at ... that its urine-based Precision Cancer Monitoring ℠ ... and monitoring of EGFR T790M mutations ... Detection of EGFR T790M Mutation in Urinary ...
Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... Intravenous Recombinant Factor IX (rFIX) Product for the Treatment ... Biopharmaceuticals, Inc., today announced the initiation of a Phase ... Factor IX (rFIX) product for control and prevention of ... is estimated that the market for therapies to treat ...
... the risk of cardiovascular hospitalization or death by 24 ... Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and ... that the ATHENA trial was published in the New ... (dronedarone), in addition to standard therapy, significantly reduced the ...
Cached Medicine Technology:Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 3New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 4New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 5New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 6
(Date:4/19/2015)... Autocarinsurancecheap.com has released a new blog post ... protection for vulnerable family members. , Accidental death ... or is disabled in an accident. The policy will ... an auto insurance plan. However, AD&D insurance can also ... life insurance policy. The newly blog post presents the ...
(Date:4/19/2015)... Carinsurancesavings.biz has released a new blog post explaining ... who have diabetes. , Clients who have diabetes ... newly released blog post explains how diabetes influences auto ... low cost coverage. , It is now possible ... single website. Clients can visit http://carinsurancesavings.biz for ...
(Date:4/19/2015)... 19, 2015 McCann Investigations, a Texas-based ... the publication of white paper Married, but Dating: ... As online media provides a unique environment of privacy, ... specifically targeting adulterous spouses has emerged. Social platforms ... as easy as shopping online. Dating sites and ...
(Date:4/18/2015)... York, NY (PRWEB) April 19, 2015 ... experienced strong growth during the past five years. The ... individuals who are unable to fully care for themselves, ... the growing need for dementia care for seniors with ... to rise at an annualized rate of 4.1% to ...
(Date:4/18/2015)... "I recognized the need for a better ... an inventor from Cincinnati, Ohio. "This need inspired me ... the Slyde Door to offer an alternative to the ... provides convenient storage space for an evacuation stretcher. The ... patients. , This offers added peace of mind ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2Health News:Finding Low Cost Auto Insurance for Diabetic Drivers! 2Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... 10 Mark Ganz, President and Chief,Executive Officer of ... of,thought leaders and health policy experts convened by The ... reframe and broaden the,national dialogue on health care reform ... The Aspen Health Stewardship Project will expand the health ...
... Women under the age of forty with breast cancer who ... as adjuvant chemotherapy, may not be benefiting from these drugs. ... levels of hormones such as estrogen, according to research published ... cancer at a young age is very worrying in terms ...
... urges Congress to,pass legislation this year to ... WASHINGTON, Oct. 10 The Health IT ... and former,Representative Nancy Johnson, today applauded Representatives ... that will bring health,information technology to all ...
... Oct. 10 XShares Advisors LLC, on behalf ... 12-month supporting,relationship with the Parkinson,s Disease Foundation (PDF), ... public advocacy. XShares, platinum level support of ... and Clinical Advances in Quality of Life,and exclusive ...
... an investment,company with a family of 20 fund portfolios, ... of its 19 currently NYSE-listed,HealthShares exchange-traded funds (ETFs) to ... requirement to transfer of all ETFs to the,NYSE Arca ... prior to,October 31, 2007. The transfer is expected to ...
... SpectraScience, Inc. (OTC,Bulletin Board: SCIE) announced today ... of the Company,s quality system from the Notified,Body ... reference to,Annex II.3 of the European directive 93/42/EEC. ... issued. Jim Hitchin the Company,s CEO said, ...
Cached Medicine News:Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 2Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 3Health News:Cancer conflict with chemotherapy treatment 2Health News:Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation 2Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 2Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 3Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 4Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 3Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 4Health News:SpectraScience Receives Final European Certification 2
... Our Hand Held Nebulizer can be held at ... It has a built in spill column, finger ... for medication setups and 7 feet of regular ... plate maintain small particle size and sustain optimum ...
... Products, ,Westmed designs, manufacturers and markets ... Respiratory professionals. Our mission is to design ... ability to deliver quality medical care while ... , ,Our web site is designed ...
... ULTRA compressor. This high output compressor can ... medication to the patient's lungs. When combined ... LC STAR® Reusable Nebulizer, the particle size ... retention into the lungs. With less medication ...
... TREK™ Compact Compressor is for active patients ... anywhere and everywhere. The compressor is small ... source optionsworldwide AC compatibility (100 to 240V), ... patients the freedom to take aerosol treatments ...
Medicine Products: